Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Abstract P032: Berzosertib plus irinotecan in patients with TP53 mutant gastric/gastroesophageal junction adenocarcinoma: A phase II study

10.1158/1535-7163.targ-21-p032 ◽

2021 ◽

Author(s):

Satya Das ◽

G. Dan Ayers ◽

Jennifer Whisenant ◽

Anwaar Saeed ◽

Edward Kim ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India

Indian Journal of Cancer ◽

10.4103/ijc.ijc_168_17 ◽

2017 ◽

Vol 54 (1) ◽

pp. 47 ◽

Cited By ~ 1

Author(s):

T Chaudhuri ◽

KG Babu ◽

KC Lakshmaiah ◽

L Dasappa ◽

LA Jacob ◽

...

Keyword(s):

Phase Ii ◽

Systemic Chemotherapy ◽

South India ◽

Phase Ii Study ◽

Locally Advanced ◽

Efficacy And Safety ◽

First Line ◽

Gastroesophageal Junction Adenocarcinoma ◽

Prospective Phase

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

Annals of Oncology ◽

10.1093/annonc/mdl459 ◽

2007 ◽

Vol 18 (3) ◽

pp. 510-517 ◽

Cited By ~ 203

Author(s):

C. Pinto ◽

F. Di Fabio ◽

S. Siena ◽

S. Cascinu ◽

F.L. Rojas Llimpe ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2257-z ◽

2013 ◽

Vol 72 (4) ◽

pp. 815-823 ◽

Cited By ~ 29

Author(s):

Inkeun Park ◽

Min-Hee Ryu ◽

Yoon Hee Choi ◽

Hyo Jeong Kang ◽

Jeong Hwan Yook ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

The Oncologist ◽

10.1634/theoncologist.2019-0330 ◽

2019 ◽

Vol 24 (8) ◽

pp. 1039 ◽

Cited By ~ 6

Author(s):

Ari Joseph Rosenberg ◽

Alfred Rademaker ◽

Howard S. Hochster ◽

Theresa Ryan ◽

Thomas Hensing ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gastroesophageal Junction Adenocarcinoma ◽

Long Term Follow Up

A Phase II Study of 5-Fluorouracil, Leucovorin, Adriamycin, and Cisplatin (FLAP) for Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

American Journal of Clinical Oncology ◽

10.1097/00000421-199706000-00006 ◽

1997 ◽

Vol 20 (3) ◽

pp. 242-246 ◽

Cited By ~ 1

Author(s):

David J. Vaughn ◽

Neal J. Meropol ◽

Christopher Holroyde ◽

David Mintzer ◽

Isaac Nuamah ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

Investigational New Drugs ◽

10.1007/s10637-006-6452-1 ◽

2006 ◽

Vol 24 (4) ◽

pp. 353-357 ◽

Cited By ~ 49

Author(s):

Jaffer A. Ajani ◽

Yixing Jiang ◽

Josephine Faust ◽

Baochong B. Chang ◽

Linus Ho ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Bryostatin 1 ◽

A phase II study of preoperative chemotherapy and chemoradiation for localized gastric and gastroesophageal junction adenocarcinoma (LGCA).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4053 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4053-4053

Author(s):

Elena Elimova ◽

Roopma Wadhwa ◽

Kazuki Sudo ◽

Hironori Shiozaki ◽

Rebecca Slack ◽

...

Keyword(s):

Phase Ii ◽

Preoperative Chemotherapy ◽

Phase Ii Study ◽

A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma

Investigational New Drugs ◽

10.1007/s10637-010-9474-7 ◽

2010 ◽

Vol 29 (6) ◽

pp. 1475-1481 ◽

Cited By ~ 29

Author(s):

Manish A. Shah ◽

Derek G. Power ◽

Hedy L. Kindler ◽

Kyle D. Holen ◽

Margaret M. Kemeny ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gastroesophageal Junction Adenocarcinoma ◽

Multicenter Phase

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

Clinical & Translational Oncology ◽

10.1007/s12094-011-0637-6 ◽

2011 ◽

Vol 13 (3) ◽

pp. 179-184 ◽

Cited By ~ 51

Author(s):

Cristina Grávalos ◽

Carlos Gómez-Martín ◽

Fernando Rivera ◽

Inmaculada Alés ◽

Bernardo Queralt ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

Gastroesophageal Junction Cancer ◽

Line Therapy